Skip to content
Search

Latest Stories

CCA calls PDA's pharmacy closure allegation 'highly inflammatory'

All pharmacy businesses are reporting that they are struggling to find the registered professionals needed to open their pharmacies, clarified the Company Chemists’ Association (CCA) in response to an attack by the Pharmacists' Defence Association.

Last week, PDA allegedly accused some large pharmacy chains of 'orchestrating' full or part-time closures of some of their shops due to the staff shortage.


In its Open Letter published on Tuesday (July 19), PDA demanded urgent action “to protect patients by ensuring that essential community pharmacy services are provided safely and consistently”.

“All parts of the healthcare system are struggling to recruit staff and to assume that pharmacies would be immune to such pressures, seems fanciful,” said CCA.

“CCA members are working extraordinarily hard to prevent temporary closures, but recruitment and retention of pharmacists is becoming increasingly tough. The recent rise in Covid cases and the beginning of the summer holiday season in parts of the UK have only worsened the situation.”

The Association also showed data from the PSNC Pharmacy Pressures Survey (April 2022) which found that 91 per cent of pharmacies are experiencing staff shortages, clearly demonstrating that these shortages are affecting the entire sector.

“To accuse some pharmacy businesses of choosing to act with impunity, to restrict patients’ access to NHS funded services is highly inflammatory. The truth of the matter is that all pharmacy businesses are reporting that they are struggling to find the registered professionals needed to open their pharmacies,” opines CCA.

It added: “Mark Koziol heard first hand from contractors of all sizes at the recent APPG inquiry, of the difficulties they are facing in finding pharmacists and technicians to allow them to open.”

“For him to deny what is plain to see is unbelievable and quite frankly insulting to all those frontline professionals who need the support that can only come from a co-ordinated approach to addressing workforce shortages across the whole of primary care.”

“We are extremely concerned that the PDA see fit to accuse large pharmacy operators of looking to misdirect healthcare systems into believing that the shortage of pharmacists being felt across the UK is a façade, being used to influence regulatory change.”

“This is categorically untrue. We believe that it is the PDA who are misleading government officials into believing that there is not a workforce crisis, in a vain attempt to continue to drive up the cost of providing healthcare across the UK.

It has been reported in the press that the NHS’s need to fund increased costs from within existing health budgets will mean having to release money from other planned frontline services.”

“We will continue to work with NHSE and DHSC to establish the facts about the scale of the workforce crisis across the UK and to find ways to make sure that the needs of all parts of primary care can be met, both in the short and longer term.”

PDA chair Koizol, who wrote the letter, went on to allege that many of those closure were “being orchestrated”.

He wrote that the “pharmacist shortage” narrative cited as a reason for these closures was “very different” from “the reality experienced by our members”, including both employed and locum pharmacists.

“We have evidence to show that these closures are being announced up to four weeks in advance."

More For You

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less